Rados Ágnes's Discussions (11)

Search Discussions

View

Discussions Replied To (10) Replies Latest Activity

"In the first few months i saw, but now in case of strenght nothing special. But he h…"

Rados Ágnes replied Nov 17, 2015 to epicatechin and Duchenne

 34 Jan 23, 2016
Reply by Steven

"Yes, David! You are right! Follidrone is -(-) epi, and just hope pure enough. It sho…"

Rados Ágnes replied Mar 24, 2015 to epicatechin and Duchenne

 34 Jan 23, 2016
Reply by Steven

"Getting harder. :((("

Rados Ágnes replied Mar 24, 2015 to epicatechin and Duchenne

 34 Jan 23, 2016
Reply by Steven

"Maybe he is just in a better shape, not improvening. Will see a few months later. Gr…"

Rados Ágnes replied Mar 24, 2015 to epicatechin and Duchenne

 34 Jan 23, 2016
Reply by Steven

"Hello! He is 10. I cant see improvement in case of walking because he has been havin…"

Rados Ágnes replied Mar 24, 2015 to epicatechin and Duchenne

 34 Jan 23, 2016
Reply by Steven

"It is really a great news!!!!  Looking forward the continuation!!! I found a few dru…"

Rados Ágnes replied Feb 13, 2015 to epicatechin and Duchenne

 34 Jan 23, 2016
Reply by Steven

"Yes your are right about the supplement industry, this is why we should choose the m…"

Rados Ágnes replied Feb 10, 2015 to epicatechin and Duchenne

 34 Jan 23, 2016
Reply by Steven

"probobly this what we are looking for: SLIM2 cianidanol powder my son have been taki…"

Rados Ágnes replied Feb 9, 2015 to epicatechin and Duchenne

 34 Jan 23, 2016
Reply by Steven

"Hello David! Do you have the slideshow of the "Mitochondrial Biogenesis in NMD"? Tha…"

Rados Ágnes replied Feb 6, 2015 to epicatechin and Duchenne

 34 Jan 23, 2016
Reply by Steven

"Hi David! I am interested in epicatechin. As you said you were on the conference. i…"

Rados Ágnes replied Feb 4, 2015 to epicatechin and Duchenne

 34 Jan 23, 2016
Reply by Steven

RSS

Need help using this community site? Visit Ning's Help Page.

Members

Events

Terms of Service

© 2019   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service